Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tamarindus indica fruit pulp extract is a botanical extract derived from the fruit of the tamarind tree, currently being investigated for its neuroprotective potential. The extract contains a complex mixture of bioactive compounds, including phenolics, flavonoids, tannins, and steroids. Its mechanism of action involves the modulation of the cholinergic system through the inhibition of acetylcholinesterase (AChE) activity, alongside potent antioxidant and anti-inflammatory effects, such as the reduction of pro-inflammatory cytokines. Preclinical studies in rat models of acrylonitrile-induced neurodegeneration suggest that the extract can attenuate oxidative stress and neuronal loss, positioning it as a potential therapeutic candidate for neurodegenerative conditions like Parkinson's disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tamarindus indica fruit pulp extract.